Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 159

1.

IV tissue plasminogen activator use in acute stroke: experience from a statewide registry.

Deng YZ, Reeves MJ, Jacobs BS, Birbeck GL, Kothari RU, Hickenbottom SL, Mullard AJ, Wehner S, Maddox K, Majid A; Paul Coverdell National Acute Stroke Registry Michigan Prototype Investigators.

Neurology. 2006 Feb 14;66(3):306-12.

PMID:
16476927
2.

Sex differences in the use of intravenous rt-PA thrombolysis treatment for acute ischemic stroke: a meta-analysis.

Reeves M, Bhatt A, Jajou P, Brown M, Lisabeth L.

Stroke. 2009 May;40(5):1743-9. doi: 10.1161/STROKEAHA.108.543181. Epub 2009 Feb 19. Review.

3.

Why are eligible thrombolysis candidates left untreated?

Hills NK, Johnston SC.

Am J Prev Med. 2006 Dec;31(6 Suppl 2):S210-6. Epub 2006 Nov 7.

PMID:
17178305
4.

The number of stroke physicians is the key to preparing IV rt-PA.

Iguchi Y, Kimura K, Shibazaki K, Aoki J.

Cerebrovasc Dis. 2009;28(5):460-7. doi: 10.1159/000235991. Epub 2009 Sep 8.

PMID:
19738375
5.

Utilization of intravenous thrombolysis in 3-4.5 hours: analysis of the Minnesota stroke registry.

Tekle WG, Chaudhry SA, Hassan AE, Peacock JM, Lakshminarayan K, Tsai A, Luepker R, Anderson DC, Qureshi AI.

Cerebrovasc Dis. 2012;34(5-6):400-5. doi: 10.1159/000343504. Epub 2012 Dec 4.

PMID:
23221276
6.

Is intra-arterial thrombolysis safe after full-dose intravenous recombinant tissue plasminogen activator for acute ischemic stroke?

Shaltoni HM, Albright KC, Gonzales NR, Weir RU, Khaja AM, Sugg RM, Campbell MS 3rd, Cacayorin ED, Grotta JC, Noser EA.

Stroke. 2007 Jan;38(1):80-4. Epub 2006 Nov 22.

7.

Neglecting the difference: does right or left matter in stroke outcome after thrombolysis?

Di Legge S, Saposnik G, Nilanont Y, Hachinski V.

Stroke. 2006 Aug;37(8):2066-9. Epub 2006 Jun 22.

8.

Hospital arrival time and intravenous t-PA use in US Academic Medical Centers, 2001-2004.

Lichtman JH, Watanabe E, Allen NB, Jones SB, Dostal J, Goldstein LB.

Stroke. 2009 Dec;40(12):3845-50. doi: 10.1161/STROKEAHA.109.562660. Epub 2009 Oct 1.

9.

The Paul Coverdell National Acute Stroke Registry: initial results from four prototypes.

Reeves MJ, Broderick JP, Frankel M, LaBresh KA, Schwamm L, Moomaw CJ, Weiss P, Katzan I; Paul Coverdell Prototype Registries Writing Group, Arora S, Heinrich JP, Hickenbottom S, Karp H, Malarcher A, Mensah G, Reeves MJ.

Am J Prev Med. 2006 Dec;31(6 Suppl 2):S202-9.

PMID:
17178304
10.

[Treatment with intravenous rt-PA in a general hospital context: A review of the Saint-Jean Hospital experience from Perpignan, France].

Sablot D, Cassarini JF, Akouz A, Benejean JM, Leibinger F, Faillie X, Vidry E, Ayrignac X, Castro S, Sinaya L, Bertrand JL, Garcia Y, Arnoud B, Negre C.

Rev Neurol (Paris). 2006 Nov;162(11):1109-17. French.

PMID:
17086147
11.

Prioritizing interventions to improve rates of thrombolysis for ischemic stroke.

California Acute Stroke Pilot Registry (CASPR) Investigators.

Neurology. 2005 Feb 22;64(4):654-9.

PMID:
15728287
12.

Is IV tissue plasminogen activator beneficial in patients with hyperdense artery sign?

Qureshi AI, Ezzeddine MA, Nasar A, Suri MF, Kirmani JF, Janjua N, Divani AA.

Neurology. 2006 Apr 25;66(8):1171-4.

PMID:
16636232
13.

Tissue plasminogen activator use: evaluation and initial management of ischemic stroke from an Iowa hospital perspective.

Albright KC, Schott TC, Jafari N, Wohlford-Wessels MP, Finnerty EP, Jacoby MR.

J Stroke Cerebrovasc Dis. 2005 May-Jun;14(3):127-35.

PMID:
17904012
14.

Variables associated with hospital arrival time after stroke: effect of delay on the clinical efficiency of early treatment.

Azzimondi G, Bassein L, Fiorani L, Nonino F, Montaguti U, Celin D, Re G, D'Alessandro R.

Stroke. 1997 Mar;28(3):537-42. Erratum in: Stroke 1997 May;28(5):1092.

15.

Acute stroke care in the US: results from 4 pilot prototypes of the Paul Coverdell National Acute Stroke Registry.

Reeves MJ, Arora S, Broderick JP, Frankel M, Heinrich JP, Hickenbottom S, Karp H, LaBresh KA, Malarcher A, Mensah G, Moomaw CJ, Schwamm L, Weiss P; Paul Coverdell Prototype Registries Writing Group.

Stroke. 2005 Jun;36(6):1232-40. Epub 2005 May 12. Erratum in: Stroke. 2005 Aug;36(8):1820.

16.

Emergency physician treatment of acute stroke with recombinant tissue plasminogen activator: a retrospective analysis.

Smith RW, Scott PA, Grant RJ, Chudnofsky CR, Frederiksen SM.

Acad Emerg Med. 1999 Jun;6(6):618-25.

17.

Determining intravenous rt-PA eligibility in the Emergency Department.

Mecozzi AC, Brown DL, Lisabeth LD, Barsan WG, Silbergleit R, Hickenbottom SL, Scott PA, Morgenstern LB.

Neurocrit Care. 2007;7(2):103-8.

PMID:
17763833
18.

[Prospects of thrombolytic therapy for acute ischemic stroke].

Nakashima T, Minematsu K.

Brain Nerve. 2009 Sep;61(9):1003-12. Review. Japanese.

PMID:
19803399
19.
20.

Survey of emergency physicians about recombinant tissue plasminogen activator for acute ischemic stroke.

Brown DL, Barsan WG, Lisabeth LD, Gallery ME, Morgenstern LB.

Ann Emerg Med. 2005 Jul;46(1):56-60.

PMID:
15988427
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk